These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 8140078)

  • 21. Dyslipoproteinaemia in manifest diabetes.
    Manzato E; Crepaldi G
    J Intern Med Suppl; 1994; 736():27-31. PubMed ID: 7986305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipid disorders in diabetes.
    Goldberg RB
    Diabetes Care; 1981; 4(5):561-72. PubMed ID: 6751732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postprandial lipoproteins in non-insulin-dependent diabetes mellitus.
    Coppack SW
    Diabet Med; 1997 Aug; 14 Suppl 3():S67-74. PubMed ID: 9272617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Lipoprotein (a) and diabetes mellitus].
    Ziegler O; Guerci B; Candiloros H; Drouin P
    Diabete Metab; 1995 Apr; 21(2):127-38. PubMed ID: 7621973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum lipids and apolipoproteins in relation to glycaemic control and diabetic nephropathy in long-term survivors of diabetes: results of the Erfurt Study.
    Schauer UJ; Pissarek D; Lundershausen R; Rühling K; Winkler L; Panzram G
    Exp Clin Endocrinol; 1988 Mar; 92(3):280-6. PubMed ID: 3267003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Dyslipidemia in diabetes mellitus: significance, diagnosis and treatment].
    Keller U; Golay A; Pometta D
    Schweiz Rundsch Med Prax; 1990 Oct; 79(41):1199-204. PubMed ID: 2237046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alterations of intestinal lipoprotein metabolism in diabetes mellitus and metabolic syndrome.
    Arca M
    Atheroscler Suppl; 2015 Feb; 17():12-6. PubMed ID: 25659871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of bezafibrate on insulin secretion and peripheral insulin sensitivity in hyperlipidemic patients with and without diabetes.
    Riccardi G; Genovese S; Saldalamacchia G; Patti L; Marotta G; Postiglione A; Rivellese A; Capaldo B; Mancini M
    Atherosclerosis; 1989 Feb; 75(2-3):175-81. PubMed ID: 2653325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathophysiology of diabetic dyslipidaemia: where are we?
    Vergès B
    Diabetologia; 2015 May; 58(5):886-99. PubMed ID: 25725623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus.
    Taskinen MR
    Diabetes; 1992 Oct; 41 Suppl 2():12-7. PubMed ID: 1526330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipids and atherogenesis in diabetes mellitus.
    Betteridge DJ
    Atherosclerosis; 1996 Jul; 124 Suppl():S43-7. PubMed ID: 8831915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperlipidemia and diabetes mellitus.
    O'Brien T; Nguyen TT; Zimmerman BR
    Mayo Clin Proc; 1998 Oct; 73(10):969-76. PubMed ID: 9787748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of diabetic dyslipoproteinemia.
    Steinmetz A
    Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):239-45. PubMed ID: 12951627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of extended-release niacin on the postprandial metabolism of Lp(a) and ApoB-100-containing lipoproteins in statin-treated men with type 2 diabetes mellitus.
    Ooi EM; Watts GF; Chan DC; Pang J; Tenneti VS; Hamilton SJ; McCormick SP; Marcovina SM; Barrett PH
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2686-93. PubMed ID: 26515419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetic dyslipidemia and atherosclerosis.
    Shepherd J
    Schweiz Med Wochenschr; 1994 Nov; 124(44):1933-7. PubMed ID: 7973520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are plasma lipoproteins responsible for the excess atherosclerosis in diabetes?
    Nikkilä EA
    Acta Endocrinol Suppl (Copenh); 1985; 272():27-30. PubMed ID: 3869424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postprandial lipemia as a cardiometabolic risk factor.
    Pirillo A; Norata GD; Catapano AL
    Curr Med Res Opin; 2014 Aug; 30(8):1489-503. PubMed ID: 24673475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Disorders of lipid metabolism in diabetes mellitus].
    Biesenbach G
    Wien Med Wochenschr Suppl; 1989; 105():9-17. PubMed ID: 2694631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diabetes and dyslipidaemia.
    Schwartz SL
    Diabetes Obes Metab; 2006 Jul; 8(4):355-64. PubMed ID: 16776742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.